Subcutaneous or Transvenous Defibrillator Therapy

Reinoud E. Knops*, Louise R. A. Olde Nordkamp, Peter-Paul H. M. Delnoy, Lucas V. A. Boersma, Juergen Kuschyk, Mikhael F. El-Chami, Hendrik Bonnemeier, Elijah R. Behr, Tom F. Brouwer, Stefan Kaab, Suneet Mittal, Anne-Floor B. E. Quast, Lonneke Smeding, Willeke van der Stuijt, Anouk de Weger, Koen C. de Wilde, Nick R. Bijsterveld, Sergio Richter, Marc A. Brouwer, Joris R. de GrootKirsten M. Kooiman, Pier D. Lambiase, Petr Neuzil, Kevin Vernooy, Marco Alings, Tim R. Betts, Frank A. L. E. Bracke, Martin C. Burke, Jonas S. S. G. de Jong, David J. Wright, Jan G. P. Tijssen, Arthur A. M. Wilde, PRAETORIAN Investigators

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)526-536
Number of pages11
JournalNew England Journal of Medicine
Volume383
Issue number6
DOIs
Publication statusPublished - 6 Aug 2020

Keywords

  • SHOCKS
  • PREVENTION
  • EFFICACY
  • OUTCOMES
  • SAFETY

Cite this